uniQure N.V. Ordinary Shares vs Teradata Corporation Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.71 (market cap $1.45B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.78B). The key difference: Teradata Corporation Common Stock is the larger of the two by market cap, and Teradata Corporation Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| QURE | TDC | |
|---|---|---|
Market Cap | $1.45B | $2.78B |
Volume | 3,323,243 | 1,442,176 |
Sector | Health | Technology |
52-Week High | $70.59 | $37.88 |
52-Week Low | $9.03 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $707.46M | $2.46B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →